- Source type
- Trial registry
- Access type
- Official
- Publisher
- ClinicalTrials.gov
- Added
- 2026-06-19
Trust profile
VV Source Trust Matrix v1.0
VV Source Trust Matrix v1.0 asks whether this source is trustworthy for the claim lane being used, not whether every possible claim from it is equally strong.
84
Clinical trial registry
- Publisher type
- Trial registry
- Bias profile
- Moderate
This source is strongest for trial discovery and safety and weaker for mechanism and consumer context.
VV Source Fit Score 1.0
Fit by use case
Fit scores are role-specific. A source can be excellent for one claim lane and weak for another.
- Regulatory status
- 64/100
- Context Source
- Clinical outcomes
- 67/100
- Context Source
- Mechanism
- 64/100
- Context Source
- Safety
- 71/100
- Context Source
- Consumer context
- 64/100
- Context Source
- Trial discovery
- 92/100
- Primary Anchor
Best used for
- Trial status
- Protocol and endpoint discovery
Weak for
- Unpublished results
- Clinical conclusions
Used in Viral Vitalism
GLP-1s Are Not Just a Weight Loss Story
Roles: Background
Show section-level references
Phase 3 trial of semaglutide in metabolic dysfunction-associated steatohepatitis
Roles: Background
Show section-level references
Related studies
Related sources
ESSENCE phase 3 trial design for semaglutide in MASH
PubMed used across the Viral Vitalism evidence library.
- Trust score
- 91
- Publisher
- PubMed
- Indexed by
- PubMed
- Access
- Abstract/index
- Usage
- 2 connections
FDA approves Wegovy for metabolic dysfunction-associated steatohepatitis with moderate-to-advanced fibrosis
U.S. Food and Drug Administration used across the Viral Vitalism evidence library.
- Trust score
- 94
- Publisher
- U.S. Food and Drug Administration
- Access
- Official
- Usage
- 6 connections
Phase 3 trial of semaglutide in metabolic dysfunction-associated steatohepatitis
PubMed used across the Viral Vitalism evidence library.
- Trust score
- 91
- Publisher
- PubMed
- Indexed by
- PubMed
- Access
- Abstract/index
- Usage
- 4 connections
Clinical Trial of Rybelsus (Semaglutide) Among Adults With Alcohol Use Disorder
Trial registry for oral semaglutide among adults with AUD.
- Trust score
- 84
- Publisher
- ClinicalTrials.gov
- Access
- Official
- Usage
- 1 connection
Does Semaglutide Reduce Alcohol Intake
Trial registry for semaglutide and alcohol intake.
- Trust score
- 84
- Publisher
- ClinicalTrials.gov
- Access
- Official
- Usage
- 1 connection
Effects of Semaglutide on Nicotine Intake
Trial registry for semaglutide and nicotine intake.
- Trust score
- 84
- Publisher
- ClinicalTrials.gov
- Access
- Official
- Usage
- 2 connections
